HomeVIV • CVE
Follow
Avivagen Inc
Previous close
$0.0050
Year range
$0.0050 - $0.080
Market cap
388.47K CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Jul 2023info | Y/Y change |
---|---|---|
Revenue | 40.52K | -16.63% |
Operating expense | 448.23K | -70.05% |
Net income | -932.92K | 50.94% |
Net profit margin | -2.30K | 41.15% |
Earnings per share | — | — |
EBITDA | -394.05K | 73.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jul 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.18K | -96.53% |
Total assets | 272.53K | -83.58% |
Total liabilities | 9.54M | 37.81% |
Total equity | -9.27M | — |
Shares outstanding | 93.29M | — |
Price to book | -0.05 | — |
Return on assets | -355.35% | — |
Return on capital | 59.58% | — |
Cash Flow
Net change in cash
(CAD) | Jul 2023info | Y/Y change |
---|---|---|
Net income | -932.92K | 50.94% |
Cash from operations | 71.51K | 106.28% |
Cash from investing | — | — |
Cash from financing | -71.22K | -142.36% |
Net change in cash | -7.00 | 100.00% |
Free cash flow | 230.55K | 127.02% |
About
Founded
2005
Headquarters
Website
Employees
13